Literature DB >> 2404466

The natural history of vasculitis. What the histology tells us about pathogenesis.

B R Smoller1, N S McNutt, F Contreras.   

Abstract

While histopathologic analysis may offer some clues as to the pathogenesis of vasculitis, observations must be interpreted with caution, as there is considerable overlap in the histologic pattern. In most cases, a predominantly neutrophilic vasculitis affecting small dermal venules suggests a relatively acute, immune complex-mediated reaction. Less commonly, this histologic pattern may be seen in non-immunologically mediated processes, such as in the presence of bacterial toxins or malignant hypertension, or in more chronic disease states, such as granuloma faciale or erythema elevatum diutinum. A predominantly lymphocytic vasculitis may represent several pathogenetic mechanisms. In lesions more than 24 to 48 hours old, a lymphocytic vasculitis may represent a resolving phase of an immune complex-mediated neutrophilic vasculitis. Alternatively, this histologic pattern may be seen de novo in conditions with a presumed cell-mediated immunologic pathogenesis. Lymphocytic vasculitis may also be seen in rickettsial infections such as Rocky Mountain spotted fever. The pathogenesis of granulomatous vasculitis remains poorly understood and is thought to be induced by a combination of circulating immune complexes and a cell-mediated immune response.

Entities:  

Mesh:

Year:  1990        PMID: 2404466

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

Review 1.  Cutaneous manifestations in systemic vasculitis.

Authors:  I Decleva; A V Marzano; M Barbareschi; E Berti
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

2.  Urticarial skin lesions and polymyositis due to lymphocytic vasculitis.

Authors:  N L Kao; H J Zeitz
Journal:  West J Med       Date:  1995-02

3.  Rocky Mountain spotted fever following cardiac transplantation.

Authors:  T M Rallis; J D Kriesel; J S Dumler; L E Wagoner; E D Wright; S L Spruance
Journal:  West J Med       Date:  1993-06

4.  Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.

Authors:  H Dauchel; P Joly; A Delpech; E Thomine; F Sauger; X Le Loet; P Lauret; F Tron; M Fontaine; J Ripoche
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

5.  Ulcerative colitis presenting as leukocytoclastic vasculitis of skin.

Authors:  Sabiye Akbulut; Ersan Ozaslan; Firdevs Topal; Levent Albayrak; Burcak Kayhan; Cumali Efe
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

6.  Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis.

Authors:  N P Burrows; F A Molina; G Terenghi; P K Clark; D O Haskard; J M Polak; R R Jones
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

7.  Hypersensitivity vasculitis induced by cefoperazone/sulbactam.

Authors:  Ismail Islek; Sancar Baris; Ali O Katranci; Ender Ariturk; Nuran Gurses
Journal:  Ann Clin Microbiol Antimicrob       Date:  2003-01-03       Impact factor: 3.944

8.  A case of Henoch-Schönlein purpura in disseminated tuberculosis.

Authors:  B G Han; S O Choi; S J Shin; H Y Kim; S H Jung; K H Lee
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.